Fluid and pharmacological agents for adhesion prevention after gynaecological surgery

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 7, 2014, Pages

  Ahmad, Gaity ^a   Mackie, Fiona L ^a   Iles, David A ^b   O'Flynn, Helena ^c   Dias, Sofia ^d   Metwally, Mostafa ^e   Watson, Andrew ^f  

^a PENNINE ACUTE HOSPITALS NHS TRUST   (United Kingdom)

^b BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^f TAMESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN DERIVATIVE; DEXTRAN; GONADORELIN AGONIST; HARTMANN SOLUTION; HEPARIN; ICODEXTRIN; N,O CARBOXYMETHYL CHITOSAN; NOXYTIOLIN; PROMETHAZINE; RETEPLASE; STEROID; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT; GEL; GLUCOCORTICOID; ORAL REHYDRATION SOLUTION; PLASMA SUBSTITUTE;

ADJUVANT THERAPY; ADVERSE OUTCOME; BIRTH RATE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG SCREENING; ECTOPIC PREGNANCY; GYNECOLOGIC SURGERY; HUMAN; LIVE BIRTH; OUTCOME ASSESSMENT; PELVIC PAIN; POSTOPERATIVE COMPLICATION; PREGNANCY RATE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SECOND LOOK SURGERY; SHORT FORM 36; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; THERAPY EFFECT; UTERUS SYNECHIA; FEMALE; GEL; INFERTILITY, FEMALE; META ANALYSIS; THERAPEUTIC USE; TISSUE ADHESIONS;

ANTICOAGULANTS; FEMALE; GELS; GLUCOCORTICOIDS; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INFERTILITY, FEMALE; PLASMA SUBSTITUTES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REHYDRATION SOLUTIONS; TISSUE ADHESIONS;

EID: 84922394078     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001298.pub4     Document Type: Review

References (60)

1. Adhesion Study Group (Buttram V, Malinak R, Cleary R, Cohen S, Cowan B, Daniell J, Maxon W, DeCherney A, Haseltine F, Haney A, March C, Soules M). Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility 1983;40:612-9.
2. Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS. Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility 2007;88(5):1413-26.
3. Peers EM, Brown CB, Adept Adhesion SG. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility 2005;84(Suppl 1):S160.
4. Coddington C, Grow D, Ahmed M, Toner J, Cook E, Diamond M. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility 2009;91:1909-13.
5. Diamond MP. Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility 1998;69(6):1067-74.
6. Diamon MP, Luciano A, Johns A, Dunn R, Young P, Bieber E. Reduction of postoperative adhesions by N, O-carboxymethylchitosan: a pilot study. Fertility and Sterility 2003;80(3):631-6.
7. diZerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D, et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction 2002;17(4):1031-8.
8. DiZerega GS, Coad J, Donnez J. Clinical evaluation of endometriosis and differential response to surgical therapy with and without application of Oxiplex/AP* adhesion barrier gel. Fertility and Sterility 2007;87:485-9.
9. Fossum GT, Silverberg KM, Miller CE, Diamond MP, Holmdahl L. Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility 2011;96:487-91.
10. Hellebrekers BWJ, Trimbos-Kemper TCM, Boesten L, Jansen FW, Kolkman W, Trimbos JB, et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility 2009;91(4):1204-14.
11. Jansen RPS. Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology 1985;153:363-71.
12. Jansen RPS. Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology & Obstetrics 1988;166:154-60.
13. Jansen RPS. Controlled clinical approaches to investigating the prevention of peritoneal adhesions. Treatment of Postsurgical Adhesions. Vol. 358, New York: Wiley-Liss Inc, 1990:177-92.
14. Johns BD, Keyport GM, Hoehler F, diZerega G. Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility 2001;76(3):595-604.
15. Larsson B, Lalos O, Marsk L, Tronstad S-E, Bygdeman M, Pehrson S, Joelsson I. Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica 1985;64:437-41.
16. LundorffP, Geldorp H, Tronstad SE, Lalos O, Larsson B, Johns DB, diZerega G. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction 2001;16(9):1982-8.
17. LundorffP, Donnez J, Korell M, Audebert AJM, Block K, diZerega GS. Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction 2004;20(2):514-20.
18. Mais V, Bracco GI, Litta P, Gargiulo, Melis GB. Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction 2006;21(5):1248-54.
19. Mettler L, Audebert A, Lehmann-Willenbrock E, Schive-Peterhansi K, Jacobs V. A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility 2004;82(2):398-404.
20. Mettler L, Hucke J, Bojahr B, Tinneberg HR, Leyland N, Avelar R. A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction 2008;23(5):1093-100.
21. Pellicano M, Bramante S, Cirillo D, Palomba S, Bifulco G, Zullo F, Nappi C. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility 2003;80(2):441-4.
22. Querleu D, Vankeerberghen-Deffense F, Bouteville C. The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 1989;18(7):935-40.
23. Rock JA, Siegler AM, Boer Miesel M, Haney AF, Rosenwaks Z, Pardo-Vargas F, et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility 1984;42:373-6.
24. Rose B, MacNeill C, Larrain R, Kopreski M. Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine 1991;36:537-9.
25. Rosenberg SM, Board JA. High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics & Gynaecology 1984;148:380-5.
26. Sites CK, Jensen BA, Glock JL, Blackman JA, Badger GJ, Joh JV, Brumsted JR. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine 1997;16(3):195-9. [MEDLINE: 9166816]
27. Ten Broek RPG, Kok-Krant N, Verhoeve HR, van Goor H, Bakkum EA. Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery 2012;9:29-35.
28. Thornton MH, Johns DB, Campeau JD, Hoehler F, DiZerega GS. Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction 1998;13(6):1480-5.
29. Trew G, Pistofidis G, Pados G, Lower A, Mettler L, Wallweiner D, et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction 2011;26(8):2015-27.
30. Young P, Johns A, Templeman C, Witz C, Webster B, Ferland R, et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility 2005;84(5):1450-6.
31. Diamond MP, Korell M, Martinez S, Kurman E, Kamar M, Adhexil Adhesion Study Group. A prospective, controlled, randomized, multicenter, exploratory pilot study evaluating the safety and potential trends in efficacy of Adhexil. Fertility and Sterility 2011;95:1086-90.
32. Imai A, Sugiyama T, Furui A, Takahashi S, Tamaya T. Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. Journal of Obstetrics and Gynecology 2003;23(6):660-63.
33. Johns DA, Ferland R, Dunn R. Initial feasibility study of a sprayable hydrogel adhesion barrier system in patients undergoing laparoscopic ovarian surgery. Journal of the American Association of Gynecologic Laparoscopists 2003;10(3):334-8.
34. Mettler L, Audebert A, Lehmann-Willenbrock E, Schive K, Jacobs VR. Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists 2003;10(3):339-44.
35. Mettler. Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences 2003;997:255-68.
36. Pellicano M, Guida M, Bramante S, Acunzo G, Di Spiezio Sardo A, Tommaselli G, et al. Reproductive outcome after autocrosslinked hyaluronic acid gel application in infertile patients who underwent laparoscopic myomectomy. Fertility and Sterility 2005;83:498-500.
37. Swolin K. Die Einwirkung von grossen intraperitonealen Dosen Glukokortikoid auf die Bildung von postoperativen Adhasionen. Acta Obstetricia et Gynaecologica Scandinavica 1967;46:204-10.
38. Tsuji S, Takahashi K, Yomo H, Fujiwara M, Kita N, Takebayashi K, et al. Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma. European Journal of Obstetrics and Gynecology 2005;123:244-8.
39. Tulandi T. Effect of intraperitoneal 32% dextran 70 on blood coagulation and serum electrolytes. Journal of Reproductive Medicine 1985;30:431-4.
40. Tulandi T. Effects of fibrin sealant on tubal anastomosis and adhesion formation. Fertility and Sterility 1991;56:136-8.
41. Hudecek R, Ivanova Z, Smerdova M, Pankova S, Krajcovicova R. Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women. Ceska Gynekol 2009;77(2):109-17.
42. Litta P, Pluchino N, Freschi L, Borgato S, Angioni S. Evaluation of adhesions after laparoscopic myomectomy using the Harmonic Ace and the auto-crosslinked hyaluronan gel vs Ringer's lactate solution. Clinical and Experimental Obstetrics and Gynecology 2013;2:210-4.
43. Tchartchian G, Dittert B, De Wilde RL. Evaluation of SprayShield in a center: randomized controlled study in women undergoing myomectomy. Gynecological Surgery 2009;Suppl 6:S72.
44. Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery. Fertility and Sterility 2008 Nov;90(5 Suppl):S144-9.
45. Cheong YC, Laird SM, Li TC, Shelton JB, Ledger WL, Cooke ID. Peritoneal healing and adhesions formation/reformation. Human Reproduction Update 2001;7:566-76.
46. Cheong Y, Sadek K, Watson A, Metwally M, Li TC. Adhesion reduction agents in gynaecological procedures: can NHS afford it?. Journal of Obstetrics and Gynaecology 2011;31:631-5.
47. De Wilde RL, Trew G. Postoperative abdominal adhesions and their prevention in gynaecological surgery. Expert consensus position. Part 2-steps to reduce adhesions. Gynaecological Surgery 2007;4(4):243-53.
48. De Wilde RL, Brölmann H, Koninckx PR, LundorffP, Lower AM, Wattiez A, et al. The Anti-Adhesions in Gynecology Expert Panel (ANGEL). Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecological Surgery 2012;9(4):365-8.
49. Diamond MP, Freeman ML. Clinical implications of postsurgical adhesions. Human Reproduction Update 2001;7:567-76.
50. diZerega G. Contemporary adhesion prevention. Fertility and Sterility 1994;61:219-35.
51. Hammoud A, Gago LA, Diamond MP. Adhesions in patients with chronic pelvic pain: a role for adhesiolysis?. Fertility and Sterility 2004;82:1483-91.
52. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
53. Hosie K, Gilbert JA, Kerr D, et al. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Delivery 2001;8:9-12.
54. Kumar S, Wong PF, Leaper DJ. Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database of Systematic Reviews 2009.
55. Lower AM, Hawthorn RJ, Ellis H, O'Brien F, Buchan S, Crowe AM. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. BJOG 2000;107:855-62.
56. Lower AM, Hawthorn RJ, Clark D, Boyd JH, Finlayson AR, Knight AD, et al. Adhesion-related readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24 046 patients. Human Reproduction 2004;19:1877-85.
57. Mais V, Cirronis MG, Peiretti M, Ferrucci G, Cossu E, Melis GB. Efficacy of auto-crosslinked hyaluronan gel for adhesion prevention in laparoscopy and hysteroscopy: a systematic review and meta-analysis of randomized controlled trials. European Journal of Obstetric and Gynaecological Reproductive Biology 2012 January;160(1):1-5.
58. Robertson D, Lefebvre G, Leyland N, Wolfman W, Allaire C, Awadalla A, et al. Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines: adhesion prevention in gynaecological surgery. International Journal of Gynaecology and Obstetrics 2010;111(2):193-7.
59. Tang CL, Jayne DG, Seow-Choen F, Ng YY, Eu KW, Mustapha N. A randomized controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following abdominal surgery. Annals of Surgery 2006r;243(4):449-55.
60. Wilson MS, Menzies D, Knight AD, Crowe AM. Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorectal Disease 2002;4:355-60.